Since MHC proteins expressed on patient lymphocytes are also expressed on brain tumor (47) but not on normal brain neurons, astrocytes, or oligodendrocytes (48), the tumor-bearing host MHC offers a means for targeted, selective killing by CTLs sensitized to them. Here, HLA-C is linked to neoplasm.